Anticipated Intraoperative Electron Beam Boost, External Beam Radiation Therapy, and Limb-Sparing Surgical Resection for Patients with Pediatric Soft-Tissue Sarcomas of the Extremity: A Multicentric Pooled Analysis of Long-Term Outcomes
Creators
- 1. Service of Radiation Oncology, Instituto de Radiomedicina, Santiago (Chile)
- 2. School of Medicine, Complutense University, Madrid (Spain)
- 3. Department of Oncology, Hospital General Universitario Gregorio Marañón, Madrid (Spain)
- 4. Service of Radiation Oncology, Hospital Universitario Ramón y Cajal, Madrid (Spain)
- 5. Service of Radiation Oncology, Clínica Universidad de Navarra, Pamplona (Spain)
- 6. Service of Radiation Oncology, Hospital General Universitario Gregorio Marañón, Madrid (Spain)
- 7. Service of Pediatric Orthopedics and Traumatology, Hospital General Universitario Gregorio Marañón, Madrid (Spain)
- 8. Service of Orthopedics and Traumatology, Clínica Universidad de Navarra, Pamplona (Spain)
Description
Purpose: To perform a joint analysis of data from 3 contributing centers within the intraoperative electron-beam radiation therapy (IOERT)-Spanish program, to determine the potential of IOERT as an anticipated boost before external beam radiation therapy in the multidisciplinary treatment of pediatric extremity soft-tissue sarcomas. Methods and Materials: From June 1993 to May 2013, 62 patients (aged <21 years) with a histologic diagnosis of primary extremity soft-tissue sarcoma with absence of distant metastases, undergoing limb-sparing grossly resected surgery, external beam radiation therapy (median dose 40 Gy) and IOERT (median dose 10 Gy) were considered eligible for this analysis. Results: After a median follow-up of 66 months (range, 4-235 months), 10-year local control, disease-free survival, and overall survival was 85%, 76%, and 81%, respectively. In multivariate analysis after adjustment for other covariates, tumor size >5 cm (P=.04) and R1 margin status (P=.04) remained significantly associated with local relapse. In regard to overall survival only margin status (P=.04) retained association on multivariate analysis. Ten patients (16%) reported severe chronic toxicity events (all grade 3). Conclusions: An anticipated IOERT boost allowed for external beam radiation therapy dose reduction, with high local control and acceptably low toxicity rates. The combined radiosurgical approach needs to be tested in a prospective trial to confirm these results
Availability note (English)
Available from http://dx.doi.org/10.1016/j.ijrobp.2014.05.026Additional details
Identifiers
- DOI
- 10.1016/j.ijrobp.2014.05.026;
- PII
- S0360-3016(14)00663-4;
Publishing Information
- Journal Title
- International Journal of Radiation Oncology, Biology and Physics
- Journal Volume
- 90
- Journal Issue
- 1
- Journal Page Range
- p. 172-180
- ISSN
- 0360-3016
- CODEN
- IOBPD3
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 46126319
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- DATA ANALYSIS; DIAGNOSIS; ELECTRON BEAMS; EXTERNAL BEAM RADIATION THERAPY; LIMBS; METASTASES; MULTIVARIATE ANALYSIS; PATIENTS; PEDIATRICS; RADIATION DOSES; SARCOMAS; SURGERY; TOXICITY
- Descriptors DEC
- BEAMS; BODY; DATA PROCESSING; DISEASES; DOSES; LEPTON BEAMS; MATHEMATICS; MEDICINE; NEOPLASMS; NUCLEAR MEDICINE; PARTICLE BEAMS; PROCESSING; RADIOLOGY; RADIOTHERAPY; STATISTICS; THERAPY
Optional Information
- Copyright
- Copyright (c) 2014 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.